Startup discovery
Search startups
Filter early-stage biotech, medtech, and health startups by stage, modality, therapeutic focus, evidence profile, fundraising readiness, and IP posture.
Private Biopharma Market Intelligence
Live private-market signal for pre-seed biopharma investors.
Track emerging startups, translational IP, patent activity, and clinical momentum in one investor-focused platform built for private biopharma scouting.
Search the Platform
Move from market signal into targeted search workflows.
Use structured search forms to move from broad market themes into specific startup sourcing and translational IP discovery, with live monitoring available on its own page.
Translational sourcing
Search IPs
Explore university and translational IP opportunities by category, institution, and theme before moving into investor-oriented analysis.
AI Platform
An agentic workflow for sourcing and tracking private biopharma opportunities.
Specialized agents search current sources, structure investor-relevant developments, and route users into deeper startup or IP diligence workflows.
Live source retrieval
Agents pull current signals from official, translational, and trusted industry sources.
Structured investor context
Market events are summarized in a consistent format with why-it-matters framing.
Search-to-diligence handoff
Move directly from the dashboard into targeted startup and IP workflows.
How It Works
Monitor the market, search the graph, then go deeper.
A tighter investor workflow for screening private biopharma opportunities from first signal through first-pass diligence.
Market monitoring
-
1
Open the live market page
Review financings, spinouts, non-dilutive funding, patents, and trial movement.
-
2
Open a search workflow
Jump into startup or IP search when a theme, region, or modality deserves focus.
-
3
Prioritize what to diligence
Use structured results and analysis views to decide where to spend partner time.
What investors get
-
1
Current source-linked context
Every dashboard item carries a source trail back to the originating signal.
-
2
Better early-stage pattern recognition
Patent and clinical-trial activity appear alongside financing and licensing momentum.
-
3
Faster sourcing loops
Move from market watch to actionable search across dedicated, focused pages.
About
Built for a private biopharma market where context compounds.
Early-stage biopharma sourcing depends on seeing fragmented signals together: grants, spinouts, IP, patents, trial movement, and early fundraising. EternaJuVita turns those fragments into a more coherent investor workflow.
Private access
Your live view into private biopharma market formation.
Open the live dashboard to monitor the market, then move into dedicated startup and IP searches when you want to source more precisely.
Contact
Start the conversation.
For investor access, data partnerships, workflow questions, or platform feedback, get in touch.
General inquiries
Use the form to ask about investor access, data partnerships, sourcing workflows, or platform questions.